The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| APPLIED GENETIC TECHNOL CORP | COM | 03820J100 | 10,021 | 1,452,216 | SH | SOLE | 1,452,216 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 10,583 | 1,356,813 | SH | SOLE | 1,356,813 | 0 | 0 | ||
| EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 18,315 | 1,599,592 | SH | SOLE | 1,599,592 | 0 | 0 | ||
| GLAUKOS CORP | COM | 377322102 | 52,242 | 1,018,362 | SH | SOLE | 1,018,362 | 0 | 0 | ||
| INVUITY INC | COM | 46187J205 | 8,588 | 1,080,272 | SH | SOLE | 1,080,272 | 0 | 0 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 2,577 | 329,942 | SH | SOLE | 329,942 | 0 | 0 | ||
| MACROGENICS INC | COM | 556099109 | 19,983 | 1,074,316 | SH | SOLE | 1,074,316 | 0 | 0 | ||
| MEI PHARMA INC | COM | 55279B202 | 940 | 580,401 | SH | SOLE | 580,401 | 0 | 0 | ||
| OBALON THERAPEUTICS INC | COM | 67424L100 | 26,226 | 2,453,338 | SH | SOLE | 2,453,338 | 0 | 0 | ||
| PARATEK PHARMACEUTICALS INC | COM | 699374302 | 9,863 | 512,366 | SH | SOLE | 512,366 | 0 | 0 | ||
| TESARO INC | COM | 881569107 | 311,033 | 2,021,403 | SH | SOLE | 2,021,403 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 33 | 8,293 | SH | SOLE | 8,293 | 0 | 0 | ||